Mental Health Clinics in Oak Creek, WI Accepting Medicare
10 Mental Health Clinics found. Showing 1 - 10
 Ray Services Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 147 W Ryan Rd, Oak Creek, WI 53154 Phone: 414-343-6414 |
Adron Psychiatry & Addiction, S.c. Counselor Medicare: Medicare Enrolled Practice Location: 9117 S 20th St, Oak Creek, WI 53154 Phone: 919-906-2322 Fax: 414-574-0011 |
Porchlight Mental Wellness Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3927 E Obrien Rd, Oak Creek, WI 53154 Phone: 414-797-3260 |
Inner Dynamics Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 8825 S. Howell Ave, #305, Oak Creek, WI 53154 Phone: 414-276-3856 Fax: 414-235-9139 |
Joshua Miller Therapy, Llc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 W Ryan Rd, Oak Creek, WI 53154 Phone: 414-928-1888 |
Therapeutic Insight Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7071 S 13th St, Oak Creek, WI 53154 Phone: 414-530-4395 |
Wisconsin Neurology Clinic, Llc Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 2603 W Rawson Ave, Suite 128, Oak Creek, WI 53154 Phone: 414-431-6760 Fax: 414-431-6761 |
Greensquare South Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7300 S 13th St, Suite 201, Oak Creek, WI 53154 Phone: 414-228-4800 Fax: 414-247-0894 |
Deaf Inspire, Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 10361 S Shepard Ave, Oak Creek, WI 53154 Phone: 414-376-6309 |
Christian Family Counseling Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 9555 S Howell Ave, Suite 750, Oak Creek, WI 53154 Phone: 414-768-9979 Fax: 414-768-9981 |
News Archive
Research provides important insight into 'systemizing' theory of autism
A new study from Cambridge University has for the first time found that autism diagnoses are more common in an IT-rich region.
Encouraging interim results from daclatasvir Phase IIb study in genotype 1 and 4 HCV patients
Bristol-Myers Squibb Company today announced interim results from a Phase IIb clinical trial (COMMAND-1) of 395 treatment-naïve, genotype 1 and 4 hepatitis C infected patients in which two doses of the investigational NS5A replication complex inhibitor daclatasvir (BMS-790052), in combination with peginterferon alfa and ribavirin (alfa/RBV), achieved higher virologic response rates through Week 12 than the alfa/RBV control group, with comparable rates of adverse events.
High court's health law consideration has political repercussions
The pending ruling could be a stamp of "repudiation or endorsement" during the upcoming election season. But, if the court overturns the health law, will the GOP be prepared to turn the decision into political victory and could that outcome have a "silver lining" for the Obama administration?
PositiveID Corporation to add complementary non-invasive glucose-level testing technologies to Healthid division
PositiveID Corporation announced today that it plans to expand its HealthID division by adding products and tools for the daily management of diabetes. In addition to the continued development of its in vivo glucose-sensing RFID microchip to detect glucose levels in the human body, the Company is planning to broaden its technology platform by adding complementary non-invasive glucose-level testing technologies.
CNIO researchers discover new specific marker for cancer stem cells
Tumours are mosaics of cells that are morphologically and molecularly very different. In this cellular heterogeneity, it is calculated that only 1-2% of the tumour mass is made up of cancer stem cells, which over the past years have been suggested to be responsible for the origin of cancer and for the resistance to conventional chemical therapies.
› Verified 3 days ago